首页> 美国卫生研究院文献>Scientia Pharmaceutica >Formulation and Optimization of Clotrimazole-Loaded Proniosomal Gel Using 32 Factorial Design
【2h】

Formulation and Optimization of Clotrimazole-Loaded Proniosomal Gel Using 32 Factorial Design

机译:克霉唑负载的前体凝胶的32因子设计与优化

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The main aim of the study was to develop and statistically optimize the proniosomal gel for enhanced transdermal delivery using 32 factorial designs to investigate the influence of both non-ionic surfactant and cholesterol to maximize the entrapment efficiency and flux. The concentration of non-ionic surfactant and cholesterol were taken as independent variables, while entrapment efficiency and flux were taken as dependent variables. The study showed that the entrapment efficiency depends on both cholesterol and surfactant, whereas permeation flux depends only on the surfactant. Proniosomal gel showed a significantly enhanced drug permeation through the skin, with an enhancement ratio 3.81±1.85 when compared to the drug solution. Comparative evaluation of permeation studies and the in vitro release study of optimized proniosomal gel (F5) with that of marketed gel and carbopol gel showed that the penetration of the optimized formulation was enhanced 1.75 times in comparison with that of the marketed formulation, and the release was in a controlled manner. Similarly, the anticandidial activity showed a significantly higher activity (p<0.05) than the marketed and carbopol gel. This may be due to the enhanced penetration of noisome-containing drug through the fungal cell wall, inhibiting the ergo sterol synthesis, thereby causing the fungal cell death due to the presence of penetration enhancer. The stability study at two different temperatures (30 ± 2°C and 4 ± 2°C) confirmed that the formulations were stable even at the end of 45 days. Hence, proniosomal gel is an efficient carrier for the delivery of clotrimazole, thereby prolonging the action.
机译:该研究的主要目的是使用3 2 因子设计开发并统计学优化用于增强透皮递送的前体凝胶,以研究非离子表面活性剂和胆固醇的影响,以最大程度地提高包封效率和通量。以非离子表面活性剂和胆固醇的浓度为自变量,而包封效率和通量为因变量。研究表明,包封率取决于胆固醇和表面活性剂,而渗透通量仅取决于表面活性剂。与药物溶液相比,前体凝胶显示出显着增强的药物透过皮肤的渗透性,增强率为3.81±1.85。渗透研究和优化的早代凝胶(F5)与市售凝胶和卡波姆凝胶的体外释放研究的比较评估表明,与市售制剂相比,优化制剂的渗透性提高了1.75倍,并且释放处于受控状态。类似地,抗螨活性显示出比市售和卡波姆凝胶显着更高的活性(p <0.05)。这可能是由于含Noosome的药物通过真菌细胞壁的渗透性增强,抑制了麦角固醇的合成,从而由于渗透促进剂的存在而导致真菌细胞死亡。在两个不同温度(30±2°C和4±2°C)下的稳定性研究证实,即使在45天结束时,该制剂也是稳定的。因此,前体凝胶是递送克霉唑的有效载体,从而延长了作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号